Latest Drug Approvals news
FDA Approves Jascayd for Progressive Pulmonary Fibrosis
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Once-Daily Pill Form of Wegovy for Weight Loss
posted December 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Subcutaneous Rybrevant Faspro for EGFR-Mutated Non-Small Cell Lung Cancer
posted December 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Fractional Exhaled Nitric Oxide Elevated in Pediatric Chest Tightness Variant Asthma 
Higher Short-Term Exposure to Pollen Linked to Lower FEV1 in COPD 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
